Curaleaf Q3 revenue rises 11% on international segment growth
Curaleaf's third-quarter revenue rose 11% year over year to $352.65 million, beating the $346.83 million analyst consensus. Adjusted EBITDA increased year over year to $78 million.
1. Quarterly results
Curaleaf reported third-quarter revenue of $352.65 million, up 11% year over year and above the $346.83 million analyst consensus. Adjusted EBITDA rose year over year to $78 million, while the company reported a loss per share of $0.14.
2. Segment growth
Revenue increased 8% in the U.S. segment and 28% internationally. The company attributed growth in part to new dispensary openings and an expanded retail footprint.
3. Cash flow target
Curaleaf continues to target about $150 million in operating cash flow for 2026 and said cannabis demand remains resilient despite consumer pressures.
